| Patient | Jim Thorpe |
|---|---|
| Date of birth | 1963-05-28 |
| Identifiers | MRN HR-ML011-SYN; SSN (made up) 000-11-9036 |
| Document date | 2026-11-01 |
| Author | Nolan Fairbanks, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
New patient with a non-healing sore on the lower lip and chest tightness on exertion: lip biopsy, coronary disease assessment, secondary prevention, and care preferences. Concerns: A sore on his lower lip has not healed for three months, and he wants to know whether it is cancer; He gets tight in the chest walking uphill and wants to stay active enough to keep coaching; He wants his care to respect who he is and to be told plainly about costs and choices. [S]
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Aspirin 81 mg delayed-release oral tablet, one tablet by mouth daily | One tablet by mouth daily | Oral route | 2026-06-08 | active | S |
| Atorvastatin 80 mg oral tablet, one tablet by mouth daily | One tablet by mouth daily | Oral route | 2026-06-08 | active | S |
| Metoprolol succinate 25 mg extended-release oral tablet, one tablet by mouth daily | One tablet by mouth daily | Oral route | 2026-06-08 | active | S |
| Nitroglycerin 0.4 mg sublingual tablet, one tablet under the tongue for chest pain, repeated every 5 minutes up to 3 tablets | One tablet under the tongue as needed for chest pain; call 911 if pain persists 5 minutes after the first tablet | Sublingual route | 2026-06-08 | active | S |
| Ezetimibe 10 mg oral tablet, one tablet by mouth daily | One tablet by mouth daily | Oral route | 2026-07-13 | active | S |
| Acetaminophen 500 mg oral tablet, two tablets by mouth every 8 hours as needed for back pain; no more than 3,000 mg a day | Two tablets by mouth every 8 hours as needed, no more than 3,000 mg a day | Oral route | 2026-08-24 to 2026-09-07 | completed | S |
| Procedure | Dates | Status | Evidence |
|---|---|---|---|
| Incisional biopsy of the left lower lip lesion under local anesthesia | 2026-06-08 to 2026-06-08 | completed | S |
| Advance care planning conversation, about 20 minutes | 2026-10-05 to 2026-10-05 | completed | S |
| Transthoracic echocardiogram | 2026-06-15 to 2026-06-15 | completed | S |
| CT of the neck with contrast before surgery | 2026-06-22 to 2026-06-22 | completed | S |
| V-excision of the left lower lip cancer with frozen-section margins and primary closure, under local anesthesia | 2026-06-29 to 2026-06-29 | completed | S |
| Low-dose CT of the chest for lung cancer screening | 2026-10-14 to 2026-10-14 | completed | S |
| Cryotherapy of two actinic keratoses on the backs of the hands | 2026-10-26 to 2026-10-26 | completed | S |
| Date | Vaccine | Status | Evidence |
|---|---|---|---|
| 2026-10-05 | Influenza vaccine, 2026-2027 season | completed | S |
| 2026-10-05 | Pneumococcal conjugate vaccine (PCV20), for chronic heart disease | completed | S |
| 2026-10-05 | Recombinant zoster vaccine, first of two doses | completed | S |
| 2026-10-26 | Tdap vaccine | completed | S |
Historical biography with true dates. These events are not part of the synthetic care timeline.
| Historical date | History | Evidence |
|---|---|---|
| 1943 | Heart attack | D (CLM-0008) |
| Relative | Condition | Age at death | Evidence |
|---|---|---|---|
| twin brother | Died of pneumonia in childhood, just short of age eight | 7 | D (CLM-0002) |
| mother | Died when he was twelve; cause not recorded in the cited source | D (CLM-0002) | |
| father | Died when he was sixteen; cause not recorded in the cited source | D (CLM-0002) |
| Concern | Status | Evidence |
|---|---|---|
| A sore on his lower lip has not healed for three months, and he wants to know whether it is cancer | active | S |
| He gets tight in the chest walking uphill and wants to stay active enough to keep coaching | active | S |
| He wants his care to respect who he is and to be told plainly about costs and choices | active | S |
Most recent measures: Leukocytes [#/volume] in Blood by Automated count 7.2 on 2026-06-08; Hemoglobin [Mass/volume] in Blood 14.8 on 2026-06-08; Platelets [#/volume] in Blood by Automated count 231 on 2026-06-08; Sodium [Moles/volume] in Serum or Plasma 140 on 2026-06-08; Potassium [Moles/volume] in Serum or Plasma 4.3 on 2026-06-08; Creatinine [Mass/volume] in Serum or Plasma 1.02 on 2026-06-08; Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M 83 on 2026-06-08; Glucose [Mass/volume] in Serum or Plasma 104 on 2026-06-08; Hemoglobin A1c/Hemoglobin.total in Blood 5.9 on 2026-06-08; Cholesterol [Mass/volume] in Serum or Plasma 118 on 2026-09-21; Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation 51 on 2026-09-21; Cholesterol in HDL [Mass/volume] in Serum or Plasma 44 on 2026-09-21; Triglyceride [Mass/volume] in Serum or Plasma 115 on 2026-09-21; Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 31 on 2026-07-13; Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 0 on 2026-10-05; Total score [AUDIT-C] 2 on 2026-10-05; Left ventricular Ejection fraction 55 on 2026-06-15 [S]
Strengths and supports: Strengths and supports: lifelong athlete who still walks and throws a ball with the young people he coaches; speaks about education and opportunity for Native youth; proud of his family and community [S]
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Non-healing lesion of the left lower lip for about three months: a 1.2 cm firm, crusted ulcer on the vermilion that bleeds when touched, on a background of dry, scaly lips from years of outdoor work; no numbness of the lip or chin and no palpable neck nodes. Suspicious for squamous cell carcinoma; incisional biopsy taken today and otolaryngology consultation booked | resolved | confirmed | K13.0 | S — Synthetic presenting problem linked to his documented lip cancer; superseded by the biopsy diagnosis. |
| Chronic coronary disease with stable exertional angina: tightness in the chest when walking uphill or carrying loads for about a year, relieved by two or three minutes of rest, never at rest; heart attack eight years ago, treated in hospital, with no regular care or medicines since. Resting ECG: sinus rhythm with Q waves in the inferior leads. Synthetic modern episode linked to his documented heart attacks | active | confirmed | I25.119 | S — Synthetic modern coding of the documented heart disease. |
| Squamous cell carcinoma of the left lower lip (external vermilion): invasive, well-differentiated keratinizing squamous cell carcinoma on incisional biopsy; 1.2 cm, no palpable neck nodes; clinical stage T1 N0 (AJCC 8th edition, lip and oral cavity). Synthetic modern episode linked to his documented lip cancer | active | confirmed | C00.1 | S — Synthetic modern diagnosis; the cited sources do not record the type of his lip cancer. |
| Acute low back strain after lifting bags of infield clay while preparing a ball field: pain across the lower back without leg pain, numbness, weakness, or bladder or bowel change; no red flags apart from a recent, fully excised early lip cancer; resolved | resolved | confirmed | S39.012A | S — Synthetic acute injury; not a historical claim. |
| Actinic keratoses: two rough, scaly patches on the backs of the hands, in sun-damaged skin; treated with cryotherapy | active | confirmed | L57.0 | S — Synthetic finding at the preventive visit, consistent with the sun-exposure history. |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 2026-06-08 | Leukocytes [#/volume] in Blood by Automated count | 7.2 | 10*3/uL | 4-11 10*3/uL | Normal | S |
| 2026-06-08 | Hemoglobin [Mass/volume] in Blood | 14.8 | g/dL | 13.2-17.1 g/dL | Normal | S |
| 2026-06-08 | Platelets [#/volume] in Blood by Automated count | 231 | 10*3/uL | 150-400 10*3/uL | Normal | S |
| 2026-06-08 | Sodium [Moles/volume] in Serum or Plasma | 140 | mmol/L | 135-145 mmol/L | Normal | S |
| 2026-06-08 | Potassium [Moles/volume] in Serum or Plasma | 4.3 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 2026-06-08 | Creatinine [Mass/volume] in Serum or Plasma | 1.02 | mg/dL | 0.74-1.35 mg/dL | Normal | S |
| 2026-06-08 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M | 83 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
| 2026-06-08 | Glucose [Mass/volume] in Serum or Plasma | 104 | mg/dL | 70-99 mg/dL | High | S |
| 2026-06-08 | Hemoglobin A1c/Hemoglobin.total in Blood | 5.9 | % | Below 5.7% is normal; 5.7 to 6.4% prediabetes | High | S |
| 2026-06-08 | Cholesterol [Mass/volume] in Serum or Plasma | 238 | mg/dL | <=199 mg/dL | High | S |
| 2026-06-08 | Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation | 158 | mg/dL | Below 100 mg/dL in general; secondary-prevention goal below 55 mg/dL | High | S |
| 2026-06-08 | Cholesterol in HDL [Mass/volume] in Serum or Plasma | 38 | mg/dL | >=40 mg/dL | Low | S |
| 2026-06-08 | Triglyceride [Mass/volume] in Serum or Plasma | 210 | mg/dL | <=149 mg/dL | High | S |
| 2026-06-08 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 24 | U/L | 7-55 U/L | Normal | S |
| 2026-06-08 | Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] | 1 | {score} | S | ||
| 2026-06-08 | Total score [AUDIT-C] | 2 | {score} | S | ||
| 2026-06-15 | Left ventricular Ejection fraction | 55 | % | Normal 52 to 72% in men | Normal | S |
| 2026-07-13 | Cholesterol [Mass/volume] in Serum or Plasma | 136 | mg/dL | <=199 mg/dL | Normal | S |
| 2026-07-13 | Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation | 68 | mg/dL | Below 100 mg/dL in general; secondary-prevention goal below 55 mg/dL | Normal | S |
| 2026-07-13 | Cholesterol in HDL [Mass/volume] in Serum or Plasma | 42 | mg/dL | >=40 mg/dL | Normal | S |
| 2026-07-13 | Triglyceride [Mass/volume] in Serum or Plasma | 130 | mg/dL | <=149 mg/dL | Normal | S |
| 2026-07-13 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 31 | U/L | 7-55 U/L | Normal | S |
| 2026-09-21 | Cholesterol [Mass/volume] in Serum or Plasma | 118 | mg/dL | <=199 mg/dL | Normal | S |
| 2026-09-21 | Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation | 51 | mg/dL | Below 100 mg/dL in general; secondary-prevention goal below 55 mg/dL | Normal | S |
| 2026-09-21 | Cholesterol in HDL [Mass/volume] in Serum or Plasma | 44 | mg/dL | >=40 mg/dL | Normal | S |
| 2026-09-21 | Triglyceride [Mass/volume] in Serum or Plasma | 115 | mg/dL | <=149 mg/dL | Normal | S |
| 2026-10-05 | Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] | 0 | {score} | S | ||
| 2026-10-05 | Total score [AUDIT-C] | 2 | {score} | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 2026-06-08 | Body height | 185 | cm | S |
| 2026-06-08 | Body weight | 94 | kg | S |
| 2026-06-08 | Body mass index (BMI) [Ratio] | 27.5 | kg/m2 | S |
| 2026-06-08 | Systolic blood pressure | 138 | mm[Hg] | S |
| 2026-06-08 | Diastolic blood pressure | 84 | mm[Hg] | S |
| 2026-06-08 | Heart rate | 78 | /min | S |
| 2026-06-08 | Respiratory rate | 14 | /min | S |
| 2026-06-08 | Body temperature | 36.7 | Cel | S |
| 2026-06-08 | Oxygen saturation in Arterial blood by Pulse oximetry | 97 | % | S |
| 2026-06-15 | Body height | 185 | cm | S |
| 2026-06-15 | Body weight | 93.8 | kg | S |
| 2026-06-15 | Body mass index (BMI) [Ratio] | 27.4 | kg/m2 | S |
| 2026-06-15 | Systolic blood pressure | 130 | mm[Hg] | S |
| 2026-06-15 | Diastolic blood pressure | 80 | mm[Hg] | S |
| 2026-06-15 | Heart rate | 64 | /min | S |
| 2026-06-15 | Respiratory rate | 14 | /min | S |
| 2026-06-15 | Body temperature | 36.6 | Cel | S |
| 2026-06-15 | Oxygen saturation in Arterial blood by Pulse oximetry | 97 | % | S |
| 2026-07-13 | Body height | 185 | cm | S |
| 2026-07-13 | Body weight | 93 | kg | S |
| 2026-07-13 | Body mass index (BMI) [Ratio] | 27.2 | kg/m2 | S |
| 2026-07-13 | Systolic blood pressure | 128 | mm[Hg] | S |
| 2026-07-13 | Diastolic blood pressure | 78 | mm[Hg] | S |
| 2026-07-13 | Heart rate | 62 | /min | S |
| 2026-07-13 | Respiratory rate | 14 | /min | S |
| 2026-07-13 | Body temperature | 36.6 | Cel | S |
| 2026-07-13 | Oxygen saturation in Arterial blood by Pulse oximetry | 97 | % | S |
| 2026-09-21 | Body height | 185 | cm | S |
| 2026-09-21 | Body weight | 91.6 | kg | S |
| 2026-09-21 | Body mass index (BMI) [Ratio] | 26.8 | kg/m2 | S |
| 2026-09-21 | Systolic blood pressure | 124 | mm[Hg] | S |
| 2026-09-21 | Diastolic blood pressure | 76 | mm[Hg] | S |
| 2026-09-21 | Heart rate | 60 | /min | S |
| 2026-09-21 | Respiratory rate | 14 | /min | S |
| 2026-09-21 | Body temperature | 36.6 | Cel | S |
| 2026-09-21 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| 2026-10-26 | Body height | 185 | cm | S |
| 2026-10-26 | Body weight | 91 | kg | S |
| 2026-10-26 | Body mass index (BMI) [Ratio] | 26.6 | kg/m2 | S |
| 2026-10-26 | Systolic blood pressure | 122 | mm[Hg] | S |
| 2026-10-26 | Diastolic blood pressure | 76 | mm[Hg] | S |
| 2026-10-26 | Heart rate | 60 | /min | S |
| 2026-10-26 | Respiratory rate | 14 | /min | S |
| 2026-10-26 | Body temperature | 36.5 | Cel | S |
| 2026-10-26 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| 2026-08-24 | Body height | 185 | cm | S |
| 2026-08-24 | Body weight | 92 | kg | S |
| 2026-08-24 | Body mass index (BMI) [Ratio] | 26.9 | kg/m2 | S |
| 2026-08-24 | Systolic blood pressure | 126 | mm[Hg] | S |
| 2026-08-24 | Diastolic blood pressure | 78 | mm[Hg] | S |
| 2026-08-24 | Heart rate | 64 | /min | S |
| 2026-08-24 | Respiratory rate | 14 | /min | S |
| 2026-08-24 | Body temperature | 36.6 | Cel | S |
| 2026-08-24 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| 2026-10-05 | Body height | 185 | cm | S |
| 2026-10-05 | Body weight | 91.4 | kg | S |
| 2026-10-05 | Body mass index (BMI) [Ratio] | 26.7 | kg/m2 | S |
| 2026-10-05 | Systolic blood pressure | 122 | mm[Hg] | S |
| 2026-10-05 | Diastolic blood pressure | 76 | mm[Hg] | S |
| 2026-10-05 | Heart rate | 60 | /min | S |
| 2026-10-05 | Respiratory rate | 14 | /min | S |
| 2026-10-05 | Body temperature | 36.6 | Cel | S |
| 2026-10-05 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| Date | Purpose | Status | Provenance |
|---|---|---|---|
| 2026-06-08 | New patient with a non-healing sore on the lower lip and chest tightness on exertion: lip biopsy, coronary disease assessment, secondary prevention, and care preferences | finished | S |
| 2026-06-15 | Lip biopsy result and otolaryngology (head and neck surgery) consultation; echocardiogram and readiness for surgery | finished | S |
| 2026-07-13 | Two weeks after excision of the lip cancer: pathology, wound check, surveillance plan, lipid recheck, and cardiac rehabilitation | finished | S |
| 2026-09-21 | Coronary disease review in cardiac rehabilitation, lipid recheck after ezetimibe, and lip surveillance | finished | S |
| 2026-10-26 | Four months after surgery: lip and neck surveillance, coronary disease review, and screening results | finished | S |
| 2026-08-24 | Same-day sick visit for low back pain | finished | S |
| 2026-10-05 | Periodic adult preventive visit | finished | S |
| Intervention | Status | Guideline | Provenance |
|---|---|---|---|
| Incisional biopsy of the lip lesion today, with pathology; sun protection for the lips and skin (lip balm with SPF 30 or higher, a broad-brimmed hat); dental review | completed | GL-NCCN-HN-2026, GL-USPSTF-SKIN-2018 | S |
| Otolaryngology (head and neck surgery) consultation for a suspected lip cancer: staging, treatment, management of the neck, and surveillance | completed | GL-NCCN-HN-2026 | S |
| Secondary prevention for chronic coronary disease: aspirin 81 mg daily, atorvastatin 80 mg with a lipid panel 4 to 12 weeks after starting and a goal LDL below 55 mg/dL, metoprolol succinate for angina, sublingual nitroglycerin with written instructions, blood pressure below 130/80, an echocardiogram to measure heart function before surgery, and staying tobacco-free | completed | GL-AHA-CCD-2023, GL-ACC-CHOL-2018, GL-CMID-2026 | S |
| Cardiac rehabilitation once the lip wound has healed: up to 36 supervised exercise and education sessions for stable angina, with nutrition, activity, and risk-factor coaching | completed | GL-AHA-CCD-2023, GL-CMID-2026 | S |
| Care organized around his choices: information about Sac and Fox Nation health services and Indian Health Service, tribal, and urban Indian health programs, help to use them if he wishes, and room for any traditional or spiritual practices he chooses; costs and options explained plainly | completed | GL-IHS-PRC | S |
| V-excision of the lip cancer under local anesthesia with 5 to 10 mm clinical margins and frozen-section margin control, primary closure; contrast CT of the neck before surgery; no elective neck dissection if the final depth of invasion is small; aspirin and metoprolol continued through surgery | completed | GL-NCCN-HN-2026, GL-AHA-PERIOP-2024 | S |
| Surveillance after lip cancer: history and examination of the lips, mouth and neck every 1 to 3 months in the first year, every 2 to 6 months in the second, every 4 to 8 months in years 3 to 5, then yearly; whole-skin examination; dental care; tobacco-free; imaging only for symptoms or findings | completed | GL-NCCN-HN-2026 | S |
| Ezetimibe 10 mg daily added to atorvastatin because LDL was 68 mg/dL, above the goal of 55 mg/dL, with a lipid panel 4 to 12 weeks later | completed | GL-AHA-CCD-2023, GL-ACC-CHOL-2018, GL-CMID-2026 | S |
| Goal | Target | Status | Outcome | Provenance |
|---|---|---|---|---|
| Lip cancer removed with clear margins and no recurrence on surveillance through four months | 2026-10-26 | completed | Excised with clear margins; no recurrence or neck nodes at four months | S |
| LDL cholesterol below 55 mg/dL on secondary prevention | 2026-09-21 | completed | LDL 51 mg/dL on atorvastatin 80 mg and ezetimibe 10 mg | S |
| Blood pressure below 130/80 mmHg | 2026-09-21 | completed | 124/76 on metoprolol | S |
| Complete cardiac rehabilitation and walk uphill without angina | 2026-10-26 | completed | 30 of 36 sessions done; no angina and no nitroglycerin use for two months | S |
| Stay tobacco-free and protect his lips and skin from the sun | 2026-10-26 | completed | Tobacco-free; lip balm with sunscreen and a hat used daily | S |